Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
BackRobo Wellness
company
About
BackRobo Wellness focuses on the areas of sleep and office, and provides healthy smart products.
- 1 - 10
Highlights
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- ¥60M
- Industries
- Medical,Sensor,Wellness
- Founded date
- Apr 1, 2019
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Bei Krypton Technology was established in April 2019. The company mainly focuses on the two areas of sleep and office, and provides healthy smart products. Backrobo owns three major brands, "Nitetronic Tianmian", "Backrobo" and "Blupeace". Nitetronic is a brand of smart anti-snoring pillows; Backrobo focuses on smart office environments, and its products are smart office chairs; Blupeace focuses on smart sleep, and its products are sleep aid mattresses.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
¥60M
BackRobo Wellness has raised a total of
¥60M
in funding over 2 rounds. Their latest funding was raised on
Apr 14, 2022 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 14, 2022 | Series A | ¥60M | 1 |
Cornerstone Capital
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
BackRobo Wellness is funded by 1 investors.
Cornerstone Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Cornerstone Capital
|
Yes | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
